FINWIRES · TerminalLIVE
FINWIRES

Optimi Health Launches Microdose Psilocybin Products for Clinical Research

By

Optimi Health (OPTI.CN) on Tuesday said it completed production of two microdose psilocybin finished drug products, formulated at 1 milligram and 2 mg dosages.

The products are available to authorized clinical research organizations. The 1mg and 2mg dosage formats extend Optimi's psilocybin range, which already includes the 5 mg capsule formulation currently prescribed for treatment-resistant depression in Australia.

"Most microdosing relies on dried mushrooms, whose psilocybin content varies widely from batch to batch. Optimi's capsules instead deliver naturally derived psilocybin at a validated, consistent dose, pairing the natural source many researchers prefer with the accurate dosage that controlled research requires," chief executive Dane Stevens said.

Optimi Health shares were last seen down $0.53 to $6.36 on the Canadian Securities Exchange.

Price: $6.15, Change: $-0.74, Percent Change: -10.74%

Related Articles

Mining & Metals

Update: SSR Mining Announces Additional $500 Million Share Buyback and Reinstatement of Quarterly Dividend

(Adds after-hours Nasdaq trading in final paragraph.)SSR Mining (SSRM.TO, SSRM) after the close Monday approved an additional $500 million for share repurchases and the reinstatement of a regular quarterly dividend as part of the company's ongoing capital returns program.These additional capital returns build on the $774 million that SSR has returned to shareholders since 2021, including $300 million in share repurchases completed in the second quarter of 2026, said executive chair Rod Antal."Year-to-date, our shareholder returns already represent a yield of approximately 5%, before giving effect to the additional $500 million authorization for share repurchases and the reinstatement of a quarterly dividend announced today. Together, these actions reinforce SSR Mining's disciplined approach to capital allocation and commitment to delivering value to shareholders," added Antal.SSR said it is in a strong financial position, supported by ongoing free cash flow generation, a robust balance sheet, and the anticipated closing of the sale of the Copler mine for $1.5 billion in cash, which remains on track to close before the end of the third quarter.Its board anticipates declaring the first quarterly cash dividend of $0.03 per common share in conjunction with the company's second quarter 2026 financial results. Annualized, the $0.12 per common share dividend provides a strong baseline of consistent capital returns to supplement the share buyback program, SSRM said.Shares of the company were last seen up US$0.59 to US$29.53 after hours. They closed up $2.37 at $40.45 on Toronto Stock Exchange.

$SSRM.TO
Mining & Metals

SSR Mining SSR Announces Additional $500 Million Share Buyback and Reinstatement of Quarterly Dividend

SSR Mining (SSRM.TO, SSRM) after the close Monday approved an additional $500 million for share repurchases and the reinstatement of a regular quarterly dividend as part of the company's ongoing capital returns program.These additional capital returns build on the $774 million that SSR has returned to shareholders since 2021, including $300 million in share repurchases completed in the second quarter of 2026, said executive chair Rod Antal."Year-to-date, our shareholder returns already represent a yield of approximately 5%, before giving effect to the additional $500 million authorization for share repurchases and the reinstatement of a quarterly dividend announced today. Together, these actions reinforce SSR Mining's disciplined approach to capital allocation and commitment to delivering value to shareholders," added Antal.SSR said it is in a strong financial position, supported by ongoing free cash flow generation, a robust balance sheet, and the anticipated closing of the sale of the Copler mine for $1.5 billion in cash, which remains on track to close before the end of the third quarter.Its board anticipates declaring the first quarterly cash dividend of $0.03 per common share in conjunction with the company's second quarter 2026 financial results. Annualized, the $0.12 per common share dividend provides a strong baseline of consistent capital returns to supplement the share buyback program, SSRM said.Shares of the company closed up $2.37 at $40.45 on Toronto Stock Exchange.

$SSRM.TO
Mining & Metals

Gold Royalty Announcing Acquisition of Additional Interest in REN Project; Involves Barrick Mining

$ABX.TO$GROY